303 related articles for article (PubMed ID: 34225369)
1. Neuropeptides, Inflammation, Biofilms, and diabetic Foot Ulcers.
Yang S; Hu L; Han R; Yang Y
Exp Clin Endocrinol Diabetes; 2022 Jul; 130(7):439-446. PubMed ID: 34225369
[TBL] [Abstract][Full Text] [Related]
2. Strategy for Treatment of Infected Diabetic Foot Ulcers.
Chang M; Nguyen TT
Acc Chem Res; 2021 Mar; 54(5):1080-1093. PubMed ID: 33596041
[TBL] [Abstract][Full Text] [Related]
3. The role of CXCL8 in chronic nonhealing diabetic foot ulcers and phenotypic changes in fibroblasts: a molecular perspective.
Rai V; Moellmer R; Agrawal DK
Mol Biol Rep; 2022 Feb; 49(2):1565-1572. PubMed ID: 35044539
[TBL] [Abstract][Full Text] [Related]
4. Proteomics and transcriptomics explore the effect of mixture of herbal extract on diabetic wound healing process.
Liu Y; Zhang X; Yang L; Zhou S; Li Y; Shen Y; Lu S; Zhou J; Liu Y
Phytomedicine; 2023 Jul; 116():154892. PubMed ID: 37267693
[TBL] [Abstract][Full Text] [Related]
5. Poorly designed research does not help clarify the role of hyperbaric oxygen in the treatment of chronic diabetic foot ulcers.
Mutluoglu M; Uzun G; Bennett M; Germonpré P; Smart D; Mathieu D
Diving Hyperb Med; 2016 Sep; 46(3):133-134. PubMed ID: 27723012
[TBL] [Abstract][Full Text] [Related]
6. Role of fibroblast plasticity and heterogeneity in modulating angiogenesis and healing in the diabetic foot ulcer.
Rai V; Moellmer R; Agrawal DK
Mol Biol Rep; 2023 Feb; 50(2):1913-1929. PubMed ID: 36528662
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of Novel Macrophage-Regulating Treatment for Wound Healing in Patients With Diabetic Foot Ulcers From the Taiwan Health Care Sector Perspective.
Su HY; Yang CY; Ou HT; Chen SG; Chen JC; Ho HJ; Kuo S
JAMA Netw Open; 2023 Jan; 6(1):e2250639. PubMed ID: 36633847
[TBL] [Abstract][Full Text] [Related]
8. Single-cell profiling reveals transcriptomic signatures of vascular endothelial cells in non-healing diabetic foot ulcers.
Lu Y; Liu X; Zhao J; Bie F; Liu Y; Xie J; Wang P; Zhu J; Xiong Y; Qin S; Yang F; Chen L; Xu Y
Front Endocrinol (Lausanne); 2023; 14():1275612. PubMed ID: 38107519
[TBL] [Abstract][Full Text] [Related]
9. Diabetic Foot Ulcers and Cardiac Autonomic Neuropathy.
Basra R; Papanas N; Farrow F; Karalliedde J; Vas P
Clin Ther; 2022 Feb; 44(2):323-330. PubMed ID: 34974945
[TBL] [Abstract][Full Text] [Related]
10. Biofilms in Diabetic Foot Ulcers: Impact, Risk Factors and Control Strategies.
Afonso AC; Oliveira D; Saavedra MJ; Borges A; Simões M
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34361044
[TBL] [Abstract][Full Text] [Related]
11. Thou shall not heal: Overcoming the non-healing behaviour of diabetic foot ulcers by engineering the inflammatory microenvironment.
Monaghan MG; Borah R; Thomsen C; Browne S
Adv Drug Deliv Rev; 2023 Dec; 203():115120. PubMed ID: 37884128
[TBL] [Abstract][Full Text] [Related]
12. Role of anaerobes in polymicrobial communities and biofilms complicating diabetic foot ulcers.
Percival SL; Malone M; Mayer D; Salisbury AM; Schultz G
Int Wound J; 2018 Oct; 15(5):776-782. PubMed ID: 29863794
[TBL] [Abstract][Full Text] [Related]
13. Toward Developing Immunocompetent Diabetic Foot Ulcer-on-a-Chip Models for Drug Testing.
Ejiugwo M; Rochev Y; Gethin G; O'Connor G
Tissue Eng Part C Methods; 2021 Feb; 27(2):77-88. PubMed ID: 33406980
[TBL] [Abstract][Full Text] [Related]
14. A Meta-Analysis of the Outcomes of Metatarsal Head Resection for the Treatment of Neuropathic Diabetic Foot Ulcers.
Yammine K; Kheir N; Assi C
Adv Wound Care (New Rochelle); 2021 Feb; 10(2):81-90. PubMed ID: 32870773
[No Abstract] [Full Text] [Related]
15. Macrophage and Neutrophil Dysregulation in Diabetic Wounds.
Clayton SM; Shafikhani SH; Soulika AM
Adv Wound Care (New Rochelle); 2024 May; ():. PubMed ID: 38695109
[TBL] [Abstract][Full Text] [Related]
16. Leveraging Potential of Nanotherapeutics in Management of Diabetic Foot Ulcer.
Pandey S; Shaif M; Ansari TM; Shamim A; Kushwaha P
Exp Clin Endocrinol Diabetes; 2022 Oct; 130(10):678-686. PubMed ID: 35240693
[TBL] [Abstract][Full Text] [Related]
17. S100A8/A9 is an important host defence mediator in neuropathic foot ulcers in patients with type 2 diabetes mellitus.
Trøstrup H; Holstein P; Christophersen L; Jørgensen B; Karlsmark T; Høiby N; Moser C; Ågren MS
Arch Dermatol Res; 2016 Jul; 308(5):347-55. PubMed ID: 27084691
[TBL] [Abstract][Full Text] [Related]
18. Discovery of β-sitosterol's effects on molecular changes in rat diabetic wounds and its impact on angiogenesis and macrophages.
Liu Y; Li Z; Li W; Chen X; Yang L; Lu S; Zhou S; Li M; Xiong W; Zhang X; Liu Y; Zhou J
Int Immunopharmacol; 2024 Jan; 126():111283. PubMed ID: 38035407
[TBL] [Abstract][Full Text] [Related]
19. The role of stem cells in the treatment of diabetic foot ulcers.
Blumberg SN; Berger A; Hwang L; Pastar I; Warren SM; Chen W
Diabetes Res Clin Pract; 2012 Apr; 96(1):1-9. PubMed ID: 22142631
[TBL] [Abstract][Full Text] [Related]
20. New Horizons of Macrophage Immunomodulation in the Healing of Diabetic Foot Ulcers.
Lin CW; Hung CM; Chen WJ; Chen JC; Huang WY; Lu CS; Kuo ML; Chen SG
Pharmaceutics; 2022 Sep; 14(10):. PubMed ID: 36297499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
